Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Tian Xu

Drosophila geneticist whose Yale lab helped show that Akt controls growth by phosphorylating the tumour suppressor Tsc2, linking the insulin pathway to TSC

Chair Professor of Genetics and Vice President, Westlake University (since 2018) · Professor of Genetics, Yale University (1993–2018) and HHMI Investigator (1997–2018) · postdoc, UC Berkeley (1990–1993) · PhD, Yale (1990)

Xu Lab, Westlake University (Hangzhou, China) ↗ Lab lineage1 direct trainee →

Tian Xu Portrait: Yale School of Medicine

Tian Xu was the senior author of the Atlas study in which his Yale group showed, in fruit flies, that Akt directly phosphorylates Tsc2, disrupts the Tsc1-Tsc2 complex and needs these phosphorylation sites to drive cell growth (POT2002). This was one of several 2002 papers, alongside mammalian cell work from other labs, that placed TSC2 downstream of Akt.

Xu studied at Fudan University, earned his PhD at Yale and did postdoctoral work at UC Berkeley. He then spent 25 years on the Yale genetics faculty, where he was also a Howard Hughes Medical Institute investigator, before moving to Westlake University in Hangzhou in 2018 as Chair Professor of Genetics and Vice President.

Milestones in the Atlas

A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.

YearEvidenceStudy
2002 M Akt regulates growth by directly phosphorylating Tsc2 POT2002 Senior author: fly genetics and biochemistry showing that Akt phosphorylates Tsc2 and that this is needed for Akt-driven growth.

Co-authors in the Atlas

People with a profile here who share at least one study with Tian Xu.

Every researcher with a profile →

← All researchers

Was this page useful?
Spotted something wrong or out of date about Tian Xu?